{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:40:14Z","timestamp":1789764014213,"version":"4.0.1"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Duchenne Muscular Dystrophy (DMD) is a rare X-linked genetic disorder caused by mutations in the dystrophin gene. The North Star Ambulatory Assessment (NSAA) and Performance of Upper Limb (PUL) are used to measure motor performance in ambulatory and non-ambulatory individuals, respectively. There is limited published qualitative evidence on what constitutes a meaningful change on either instrument. The aim of this study is to understand meaningful change in functional abilities as measured by the NSAA and PUL at different ability levels from the perspective of individuals with DMD, caregivers of individuals with DMD, and clinicians.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The study utilized a non-interventional, descriptive, cross-sectional qualitative design consisting of 69 semi-structured interviews, including individuals with DMD (<jats:italic>n<\/jats:italic>\u202f=\u202f18), caregivers of individuals with DMD (<jats:italic>n<\/jats:italic>\u202f=\u202f51), and neuromuscular physiotherapists (<jats:italic>n<\/jats:italic>\u202f=\u202f2) to understand meaningful change on the NSAA and PUL.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The results for both instruments indicated that: (i) items that are meaningful differ based on ability level; (ii) maintaining function in lower and upper limbs is the ultimate goal; (iii) meaningful change is often reported in relation to gain or loss of specific function, as opposed to number of total points on the scale; and (iv) losing one scale point corresponds to either a partial or full loss in function and activity, which has differing impacts on daily life.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The perception of meaningful change in DMD as measured by the NSAA is influenced by ability levels and ambulatory function, with participants describing their need to maximize certain abilities, maintain function, and retain independence. For the PUL, participants underscored the importance of maintenance of their functional abilities, and highlighted key themes related to maintaining independence in ADLs, reaching, eating\/drinking, and finger function for technology use across score categories.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2025.1509174","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T13:31:00Z","timestamp":1741095060000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["A patient-centered qualitative evaluation of meaningful change on the NSAA and PUL in Duchenne Muscular Dystrophy"],"prefix":"10.3389","volume":"16","author":[{"given":"Aviva","family":"Gillman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teofil","family":"Ciobanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan W.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander P.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phoebe","family":"Heinrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystian","family":"Przydzial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany","family":"Ewens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerrit","family":"Vandenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Mayhew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol"},{"key":"ref2","article-title":"Duchenne and Becker muscular dystrophy: Management and prognosis","volume-title":"UpToDate","author":"Darras","year":"2022"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13023-017-0631-3","article-title":"The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review","volume":"12","author":"Ryder","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"236","DOI":"10.4103\/0028-3886.43441","article-title":"Duchenne muscular dystrophy","volume":"56","author":"Yiu","year":"2008","journal-title":"Neurology India"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1136\/archdischild-2014-306366","article-title":"Improving recognition of Duchenne muscular dystrophy: a retrospective case note review","volume":"99","author":"van Ruiten","year":"2014","journal-title":"Arch Dis Child"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e2304","DOI":"10.1212\/WNL.0000000000012910","article-title":"Life expectancy in Duchenne muscular dystrophy: reproduced individual patient data Meta-analysis","volume":"97","author":"Broomfield","year":"2021","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.coph.2017.04.002","article-title":"Pharmacological advances for treatment in Duchenne muscular dystrophy","volume":"34","author":"Guiraud","year":"2017","journal-title":"Curr Opin Pharmacol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13023-021-01758-9","article-title":"Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: can we do better?","volume":"16","author":"Kourakis","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/pri.520","article-title":"Development of a functional assessment scale for ambulatory boys with Duchenne muscular dystrophy","volume":"17","author":"Scott","year":"2011","journal-title":"Physiother Res Int"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/dmcn.12213","article-title":"Development of the performance of the upper limb module for Duchenne muscular dystrophy","volume":"55","author":"Mayhew","year":"2013","journal-title":"Dev Med Child Neurol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s41687-019-0100-y","article-title":"An overview of using qualitative techniques to explore and define estimates of clinically important change on clinical outcome assessments","volume":"3","author":"Staunton","year":"2019","journal-title":"J Patient Rep Outcomes"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s11136-023-03413-1","article-title":"Introduction to the special section: \u201cmethodologies and considerations for meaningful change\u201d","volume":"32","author":"Trigg","year":"2023","journal-title":"Qual Life Res"},{"key":"ref13","volume-title":"Patient-focused drug development: selecting, developing, or modifying fit-for-purpose clinical outcome assessments. Guidance for industry, Food and Drug Administration staff, and other stakeholders","year":"2022"},{"key":"ref14","volume-title":"Patient-focused drug development: incorporating clinical outcome assessments into endpoints for regulatory decision-making. Guidance for industry, Food and Drug Administration staff, and other stakeholders","year":"2023"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1111\/dmcn.12220","article-title":"Detecting meaningful change using the north star ambulatory assessment in Duchenne muscular dystrophy","volume":"55","author":"Mayhew","year":"2013","journal-title":"Dev Med Child Neurol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e0283669","DOI":"10.1371\/journal.pone.0283669","article-title":"Determining minimal clinically important differences in the north star ambulatory assessment (NSAA) for patients with Duchenne muscular dystrophy","volume":"18","author":"Ayyar Gupta","year":"2023","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"Int J Qual Health Care"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qual Res Psychol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s41687-023-00669-6","article-title":"A qualitative study to understand the Duchenne muscular dystrophy experience from the parent\/patient perspective","volume":"7","author":"Brown","year":"2023","journal-title":"J Patient Rep Outcomes"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"S218","DOI":"10.1016\/j.jval.2021.11.1064","article-title":"POSA353 conceptual models of the patient experience of Duchenne muscular dystrophy constructed from a qualitative interview study with caregivers","volume":"25","author":"Iff","year":"2022","journal-title":"Value Health"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s11136-022-03240-w","article-title":"A comprehensive qualitative framework for health-related quality of life in Duchenne muscular dystrophy","volume":"32","author":"Powell","year":"2023","journal-title":"Qual Life Res"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s41687-021-00341-x","article-title":"Symptoms and impacts of ambulatory nonsense mutation Duchenne muscular dystrophy: a qualitative study and the development of a patient-centred conceptual model","volume":"5","author":"Williams","year":"2021","journal-title":"J Patient Rep Outcomes"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s12955-018-1062-0","article-title":"A review of quality of life themes in Duchenne muscular dystrophy for patients and carers","volume":"16","author":"Uttley","year":"2018","journal-title":"Health Qual Life Outcomes"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1212\/WNL.0000000000001336","article-title":"Measuring quality of life in muscular dystrophy","volume":"84","author":"Bann","year":"2015","journal-title":"Neurology"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e0213649","DOI":"10.1371\/journal.pone.0213649","article-title":"Gene therapy as a potential therapeutic option for Duchenne muscular dystrophy: a qualitative preference study of patients and parents","volume":"14","author":"Landrum Peay","year":"2019","journal-title":"PLoS One"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12883-017-0853-y","article-title":"A qualitative study of perceptions of meaningful change in spinal muscular atrophy","volume":"17","author":"McGraw","year":"2017","journal-title":"BMC Neurol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"S124","DOI":"10.1016\/j.nmd.2018.06.356","article-title":"DUCHENNE MUSCULAR DYSTROPHY-PHYSIOTHERAPY: P. 308Determination of the minimal clinically important difference (MCID) for clinical trial outcome measures in Duchenne muscular dystrophy","volume":"28","author":"Pitchforth","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"03.CP.3.4","DOI":"10.2466\/03.CP.3.4","article-title":"Achieving saturation in thematic analysis: development and refinement of a codebook","volume":"3","author":"Ando","year":"2014","journal-title":"Comprehensive Psychol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejpn.2024.09.004","article-title":"Understanding north star ambulatory assessment total scores and their implications for standards of care using observational data","volume":"53","author":"Stimpson","year":"2024","journal-title":"Eur J Paediatr Neurol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/j.clinthera.2016.04.001","article-title":"Engaging participants in rare disease research: a qualitative study of Duchenne muscular dystrophy","volume":"38","author":"Bendixen","year":"2016","journal-title":"Clin Ther"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/1525822X05279903","article-title":"How many interviews are enough?: an experiment with data saturation and variability","volume":"18","author":"Guest","year":"2006","journal-title":"Field Methods"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12883-021-02166-z","article-title":"Understanding the relationship between the 32-item motor function measure and daily activities from an individual with spinal muscular atrophy and their caregivers\u2019 perspective: a two-part study","volume":"21","author":"Duong","year":"2021","journal-title":"BMC Neurol"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1509174\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T13:31:09Z","timestamp":1741095069000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1509174\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":32,"alternative-id":["10.3389\/fneur.2025.1509174"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1509174","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]},"article-number":"1509174"}}